ID   AMD_RAT                 Reviewed;         976 AA.
AC   P14925; P70710; Q64616; Q64668;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   29-MAY-2024, entry version 210.
DE   RecName: Full=Peptidylglycine alpha-amidating monooxygenase {ECO:0000303|PubMed:10504734};
DE            Short=PAM {ECO:0000303|PubMed:10504734};
DE   Includes:
DE     RecName: Full=Peptidylglycine alpha-hydroxylating monooxygenase {ECO:0000303|PubMed:10504734};
DE              Short=PHM {ECO:0000303|PubMed:10504734};
DE              EC=1.14.17.3 {ECO:0000269|PubMed:10079066};
DE   Includes:
DE     RecName: Full=Peptidyl-alpha-hydroxyglycine alpha-amidating lyase {ECO:0000303|PubMed:10504734};
DE              EC=4.3.2.5 {ECO:0000269|PubMed:10079066};
DE     AltName: Full=Peptidylamidoglycolate lyase {ECO:0000303|PubMed:10079066};
DE              Short=PAL {ECO:0000303|PubMed:10079066};
DE   Flags: Precursor;
GN   Name=Pam {ECO:0000303|PubMed:10079066, ECO:0000312|RGD:3252};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (PAM-1/2).
RC   STRAIN=Sprague-Dawley; TISSUE=Heart atrium;
RX   PubMed=2911604; DOI=10.1073/pnas.86.2.735;
RA   Stoffers D.A., Green C.B.R., Eipper B.A.;
RT   "Alternative mRNA splicing generates multiple forms of peptidyl-glycine
RT   alpha-amidating monooxygenase in rat atrium.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:735-739(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (PAM-3/4).
RC   STRAIN=Sprague-Dawley; TISSUE=Heart atrium;
RX   PubMed=1988445; DOI=10.1016/s0021-9258(18)52352-8;
RA   Stoffers D.A., Ouafik L., Eipper B.A.;
RT   "Characterization of novel mRNAs encoding enzymes involved in peptide
RT   alpha-amidation.";
RL   J. Biol. Chem. 266:1701-1707(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (PAM-1 TO 5).
RC   STRAIN=Wistar; TISSUE=Pituitary;
RX   PubMed=2401356; DOI=10.1016/0014-5793(90)81184-p;
RA   Kato I., Yonekura H., Yamamoto H., Okamoto H.;
RT   "Isolation and functional expression of pituitary peptidylglycine alpha-
RT   amidating enzyme mRNA. A variant lacking the transmembrane domain.";
RL   FEBS Lett. 269:319-323(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (PAM-4).
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2337358; DOI=10.1016/0003-9861(90)90466-c;
RA   Bertelsen A.H., Beaudry G.A., Galella E.A., Jones B.N., Ray M.L.,
RA   Mehta N.M.;
RT   "Cloning and characterization of two alternatively spliced rat alpha-
RT   amidating enzyme cDNAs from rat medullary thyroid carcinoma.";
RL   Arch. Biochem. Biophys. 279:87-96(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RX   PubMed=1740449; DOI=10.1016/s0021-9258(19)50625-1;
RA   Eipper B.A., Green C.B., Campbell T.A., Stoffers D.A., Keutmann H.T.,
RA   Mains R.E., Ouafik L.;
RT   "Alternative splicing and endoproteolytic processing generate tissue-
RT   specific forms of pituitary peptidylglycine alpha-amidating monooxygenase
RT   (PAM).";
RL   J. Biol. Chem. 267:4008-4015(1992).
RN   [6]
RP   PROTEIN SEQUENCE OF 26-42, AND GLYCOSYLATION AT ASN-765.
RX   PubMed=2211657; DOI=10.1016/s0021-9258(18)38219-x;
RA   Beaudry G.A., Mehta N.M., Ray M.L., Bertelsen A.H.;
RT   "Purification and characterization of functional recombinant alpha-
RT   amidating enzyme secreted from mammalian cells.";
RL   J. Biol. Chem. 265:17694-17699(1990).
RN   [7]
RP   ALTERNATIVE SPLICING.
RX   PubMed=1448112; DOI=10.1210/mend.6.10.1448112;
RA   Ouafik L.H., Stoffers D.A., Campbell T.A., Johnson R.C., Bloomquist B.T.,
RA   Mains R.E., Eipper B.A.;
RT   "The multifunctional peptidylglycine alpha-amidating monooxygenase gene:
RT   exon/intron organization of catalytic, processing, and routing domains.";
RL   Mol. Endocrinol. 6:1571-1584(1992).
RN   [8]
RP   INTERACTION WITH RASSF9.
RX   PubMed=9837933; DOI=10.1074/jbc.273.50.33524;
RA   Chen L., Johnson R.C., Milgram S.L.;
RT   "P-CIP1, a novel protein that interacts with the cytosolic domain of
RT   peptidylglycine alpha-amidating monooxygenase, is associated with
RT   endosomes.";
RL   J. Biol. Chem. 273:33524-33532(1998).
RN   [9]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10079066; DOI=10.1021/bi982255j;
RA   Wilcox B.J., Ritenour-Rodgers K.J., Asser A.S., Baumgart L.E.,
RA   Baumgart M.A., Boger D.L., DeBlassio J.L., deLong M.A., Glufke U.,
RA   Henz M.E., King L. III, Merkler K.A., Patterson J.E., Robleski J.J.,
RA   Vederas J.C., Merkler D.J.;
RT   "N-acylglycine amidation: implications for the biosynthesis of fatty acid
RT   primary amides.";
RL   Biochemistry 38:3235-3245(1999).
RN   [10]
RP   DISULFIDE BONDS IN CATALYTIC DOMAIN.
RX   PubMed=12369828; DOI=10.1021/bi0260280;
RA   Kolhekar A.S., Bell J., Shiozaki E.N., Jin L., Keutmann H.T., Hand T.A.,
RA   Mains R.E., Eipper B.A.;
RT   "Essential features of the catalytic core of peptidyl-alpha-hydroxyglycine
RT   alpha-amidating lyase.";
RL   Biochemistry 41:12384-12394(2002).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-945; SER-949; THR-959 AND
RP   SER-961, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12] {ECO:0007744|PDB:1OPM, ECO:0007744|PDB:3PHM}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 45-354 IN COMPLEX WITH CU(2+),
RP   AND COFACTOR.
RX   PubMed=10504734; DOI=10.1038/13351;
RA   Prigge S.T., Kolhekar A.S., Eipper B.A., Mains R.E., Amzel L.M.;
RT   "Substrate-mediated electron transfer in peptidylglycine alpha-
RT   hydroxylating monooxygenase.";
RL   Nat. Struct. Biol. 6:976-983(1999).
RN   [13] {ECO:0007744|PDB:3FVZ, ECO:0007744|PDB:3FW0}
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 498-820 IN COMPLEX WITH ZINC;
RP   CALCIUM AND ALPHA-HYDROXYHIPPURIC ACID, COFACTOR, MUTAGENESIS OF ARG-533;
RP   ARG-706; MET-784 AND ASP-787, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY
RP   REGULATION, AND REGION.
RX   PubMed=19604476; DOI=10.1016/j.str.2009.05.008;
RA   Chufan E.E., De M., Eipper B.A., Mains R.E., Amzel L.M.;
RT   "Amidation of bioactive peptides: the structure of the lyase domain of the
RT   amidating enzyme.";
RL   Structure 17:965-973(2009).
CC   -!- FUNCTION: Bifunctional enzyme that catalyzes the post-translational
CC       modification of inactive peptidylglycine precursors to the
CC       corresponding bioactive alpha-amidated peptides, a terminal
CC       modification in biosynthesis of many neural and endocrine peptides (By
CC       similarity). Alpha-amidation involves two sequential reactions, both of
CC       which are catalyzed by separate catalytic domains of the enzyme. The
CC       first step, catalyzed by peptidyl alpha-hydroxylating monooxygenase
CC       (PHM) domain, is the copper-, ascorbate-, and O2- dependent
CC       stereospecific hydroxylation (with S stereochemistry) at the alpha-
CC       carbon (C-alpha) of the C-terminal glycine of the peptidylglycine
CC       substrate (PubMed:10079066). The second step, catalyzed by the
CC       peptidylglycine amidoglycolate lyase (PAL) domain, is the zinc-
CC       dependent cleavage of the N-C-alpha bond, producing the alpha-amidated
CC       peptide and glyoxylate (PubMed:10079066). Similarly, catalyzes the two-
CC       step conversion of an N-fatty acylglycine to a primary fatty acid amide
CC       and glyoxylate (PubMed:10079066). {ECO:0000250|UniProtKB:P10731,
CC       ECO:0000250|UniProtKB:P19021, ECO:0000269|PubMed:10079066}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a [peptide]-C-terminal glycine + 2 L-ascorbate + O2 = a
CC         [peptide]-C-terminal (2S)-2-hydroxyglycine + H2O + 2 monodehydro-L-
CC         ascorbate radical; Xref=Rhea:RHEA:21452, Rhea:RHEA-COMP:13486,
CC         Rhea:RHEA-COMP:15321, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:38290, ChEBI:CHEBI:59513, ChEBI:CHEBI:137000,
CC         ChEBI:CHEBI:142768; EC=1.14.17.3;
CC         Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a [peptide]-C-terminal (2S)-2-hydroxyglycine = a [peptide]-C-
CC         terminal amide + glyoxylate; Xref=Rhea:RHEA:20924, Rhea:RHEA-
CC         COMP:13485, Rhea:RHEA-COMP:15321, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:137001, ChEBI:CHEBI:142768; EC=4.3.2.5;
CC         Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 L-ascorbate + N-dodecanoylglycine + O2 = H2O + 2
CC         monodehydro-L-ascorbate radical + N-dodecanoyl-(2S)-hydroxyglycine;
CC         Xref=Rhea:RHEA:58540, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:38290, ChEBI:CHEBI:59513, ChEBI:CHEBI:142678,
CC         ChEBI:CHEBI:142693; Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-dodecanoyl-(2S)-hydroxyglycine = dodecanamide + glyoxylate;
CC         Xref=Rhea:RHEA:58624, ChEBI:CHEBI:34726, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:142693; Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 L-ascorbate + N-(9Z,12Z,15Z)-octadecatrienoylglycine + O2 =
CC         H2O + 2 monodehydro-L-ascorbate radical + N-(9Z,12Z,15Z)-
CC         octadecatrienoyl-(2S)-hydroxyglycine; Xref=Rhea:RHEA:58548,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:38290,
CC         ChEBI:CHEBI:59513, ChEBI:CHEBI:142679, ChEBI:CHEBI:142697;
CC         Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(9Z,12Z,15Z)-octadecatrienoyl-(2S)-hydroxyglycine =
CC         (9Z,12Z,15Z)-octadecatrienamide + glyoxylate; Xref=Rhea:RHEA:58644,
CC         ChEBI:CHEBI:36655, ChEBI:CHEBI:142684, ChEBI:CHEBI:142697;
CC         Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 L-ascorbate + N-(9Z-octadecenoyl)glycine + O2 = H2O + 2
CC         monodehydro-L-ascorbate radical + N-(9Z-octadecenoyl)-(2S)-
CC         hydroxyglycine; Xref=Rhea:RHEA:58600, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:38290, ChEBI:CHEBI:59513,
CC         ChEBI:CHEBI:133992, ChEBI:CHEBI:142696;
CC         Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-(9Z-octadecenoyl)-(2S)-hydroxyglycine = (9Z)-octadecenamide
CC         + glyoxylate; Xref=Rhea:RHEA:58636, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:116314, ChEBI:CHEBI:142696;
CC         Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 L-ascorbate + N-tetradecanoylglycine + O2 = H2O + 2
CC         monodehydro-L-ascorbate radical + N-tetradecanoyl-(2S)-
CC         hydroxyglycine; Xref=Rhea:RHEA:58544, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:38290, ChEBI:CHEBI:59513,
CC         ChEBI:CHEBI:86500, ChEBI:CHEBI:142694;
CC         Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-tetradecanoyl-(2S)-hydroxyglycine = glyoxylate +
CC         tetradecamide; Xref=Rhea:RHEA:58632, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:137125, ChEBI:CHEBI:142694;
CC         Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 L-ascorbate + N-decanoylglycine + O2 = H2O + 2 monodehydro-
CC         L-ascorbate radical + N-decanoyl-(2S)-hydroxyglycine;
CC         Xref=Rhea:RHEA:58608, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:38290, ChEBI:CHEBI:59513, ChEBI:CHEBI:142680,
CC         ChEBI:CHEBI:142692; Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-decanoyl-(2S)-hydroxyglycine = decanamide + glyoxylate;
CC         Xref=Rhea:RHEA:58620, ChEBI:CHEBI:36655, ChEBI:CHEBI:38833,
CC         ChEBI:CHEBI:142692; Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 L-ascorbate + N-octanoylglycine + O2 = H2O + 2 monodehydro-
CC         L-ascorbate radical + N-octanoyl-(2S)-hydroxyglycine;
CC         Xref=Rhea:RHEA:58612, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:38290, ChEBI:CHEBI:59513, ChEBI:CHEBI:142681,
CC         ChEBI:CHEBI:142691; Evidence={ECO:0000269|PubMed:10079066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-octanoyl-(2S)-hydroxyglycine = glyoxylate + octanamide;
CC         Xref=Rhea:RHEA:58616, ChEBI:CHEBI:36655, ChEBI:CHEBI:142682,
CC         ChEBI:CHEBI:142691; Evidence={ECO:0000269|PubMed:10079066};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds one Zn(2+) ion per subunit. {ECO:0000269|PubMed:19604476};
CC   -!- COFACTOR:
CC       Name=Cu(2+); Xref=ChEBI:CHEBI:29036;
CC       Note=Binds 2 Cu(2+) ions per subunit. {ECO:0000269|PubMed:10504734};
CC   -!- ACTIVITY REGULATION: PAM activity is inhibited by EDTA, phenylglyoxal
CC       and diethyl pyrocarbonate (By similarity). PAL activity is stimulated
CC       by cadmium and inhibited by mercury (PubMed:19604476).
CC       {ECO:0000250|UniProtKB:P19021, ECO:0000269|PubMed:19604476}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=13.8 uM for [peptide]-C-terminal (2S)-2-hydroxyglycine
CC         {ECO:0000269|PubMed:19604476};
CC   -!- SUBUNIT: Monomer. Interacts with RASSF9. {ECO:0000269|PubMed:9837933}.
CC   -!- INTERACTION:
CC       P14925; O88869: Rassf9; NbExp=3; IntAct=EBI-1395008, EBI-1395057;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000250|UniProtKB:P10731}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:P10731}. Note=Secretory granules.
CC       {ECO:0000250|UniProtKB:P10731}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=PAM-1;
CC         IsoId=P14925-1; Sequence=Displayed;
CC       Name=PAM-2;
CC         IsoId=P14925-2; Sequence=VSP_001232;
CC       Name=PAM-3;
CC         IsoId=P14925-3; Sequence=VSP_001232, VSP_001234;
CC       Name=PAM-3A;
CC         IsoId=P14925-4; Sequence=VSP_001232, VSP_001233;
CC       Name=PAM-3B;
CC         IsoId=P14925-5; Sequence=VSP_001232, VSP_001235;
CC       Name=PAM-4;
CC         IsoId=P14925-6; Sequence=VSP_001236, VSP_001237;
CC       Name=PAM-5;
CC         IsoId=P14925-7; Sequence=VSP_001230, VSP_001231;
CC   -!- MISCELLANEOUS: [Isoform PAM-1]: Membrane-bound.
CC   -!- MISCELLANEOUS: [Isoform PAM-2]: Membrane-bound. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform PAM-3]: Soluble. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform PAM-3A]: Soluble. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform PAM-3B]: Membrane-bound. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform PAM-4]: Soluble. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform PAM-5]: Soluble. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the peptidyl-alpha-
CC       hydroxyglycine alpha-amidating lyase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the copper type II
CC       ascorbate-dependent monooxygenase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA42068.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U52650; AAC05602.1; -; Genomic_DNA.
DR   EMBL; U52639; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52640; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52641; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52642; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52643; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52644; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52645; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52646; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52647; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52648; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52649; AAC05602.1; JOINED; Genomic_DNA.
DR   EMBL; U52653; AAC05603.1; -; Genomic_DNA.
DR   EMBL; U52639; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52640; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52641; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52642; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52643; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52644; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52645; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52646; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52647; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52648; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52649; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52651; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52652; AAC05603.1; JOINED; Genomic_DNA.
DR   EMBL; U52664; AAC05607.1; -; Genomic_DNA.
DR   EMBL; U52639; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52640; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52641; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52642; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52643; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52644; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52645; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52646; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52647; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52648; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52649; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52651; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52652; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52653; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52654; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52655; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52656; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52657; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52658; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52659; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52660; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52661; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52662; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52663; AAC05607.1; JOINED; Genomic_DNA.
DR   EMBL; U52664; AAC05605.1; -; Genomic_DNA.
DR   EMBL; U52639; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52640; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52641; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52642; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52643; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52644; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52645; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52646; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52647; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52648; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52649; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52651; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52652; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52654; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52655; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52656; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52657; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52658; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52659; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52660; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52661; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52662; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52663; AAC05605.1; JOINED; Genomic_DNA.
DR   EMBL; U52664; AAC05604.1; -; Genomic_DNA.
DR   EMBL; U52639; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52640; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52641; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52642; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52643; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52644; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52645; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52646; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52647; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52648; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52649; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52651; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52652; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52654; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52655; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52656; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52657; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52658; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52659; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52660; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52661; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52662; AAC05604.1; JOINED; Genomic_DNA.
DR   EMBL; U52664; AAC05608.1; -; Genomic_DNA.
DR   EMBL; U52639; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52640; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52641; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52642; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52643; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52644; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52645; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52646; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52647; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52648; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52649; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52651; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52652; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52654; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52655; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52656; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52657; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52658; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52659; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52660; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52661; AAC05608.1; JOINED; Genomic_DNA.
DR   EMBL; U52664; AAC05606.1; -; Genomic_DNA.
DR   EMBL; U52639; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52640; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52641; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52642; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52643; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52644; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52645; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52646; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52647; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52648; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52649; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52651; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52652; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52654; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52655; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52656; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52657; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52658; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52659; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52660; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52661; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; U52663; AAC05606.1; JOINED; Genomic_DNA.
DR   EMBL; M25732; AAA41803.1; -; mRNA.
DR   EMBL; M25719; AAA41804.1; -; mRNA.
DR   EMBL; M63662; AAA42068.1; ALT_SEQ; mRNA.
DR   EMBL; X59685; CAA42206.1; -; mRNA.
DR   EMBL; X59686; CAA42207.1; -; mRNA.
DR   EMBL; X59687; CAA42208.1; -; mRNA.
DR   EMBL; X59688; CAA42209.1; -; mRNA.
DR   EMBL; X59689; CAA42210.1; -; mRNA.
DR   EMBL; M82845; AAB00162.1; -; mRNA.
DR   PIR; A32193; URRTAP.
DR   RefSeq; NP_037132.2; NM_013000.2. [P14925-1]
DR   RefSeq; XP_006245660.1; XM_006245598.3.
DR   RefSeq; XP_006245661.1; XM_006245599.3.
DR   PDB; 1OPM; X-ray; 2.10 A; A=45-354.
DR   PDB; 1PHM; X-ray; 1.90 A; A=45-354.
DR   PDB; 1SDW; X-ray; 1.85 A; A=43-356.
DR   PDB; 1YI9; X-ray; 1.70 A; A=47-355.
DR   PDB; 1YIP; X-ray; 2.20 A; A=45-355.
DR   PDB; 1YJK; X-ray; 2.00 A; A=50-355.
DR   PDB; 1YJL; X-ray; 2.40 A; A=50-355.
DR   PDB; 3FVZ; X-ray; 2.35 A; A=498-820.
DR   PDB; 3FW0; X-ray; 2.52 A; A=498-820.
DR   PDB; 3MIB; X-ray; 2.35 A; A=43-356.
DR   PDB; 3MIC; X-ray; 2.42 A; A=43-356.
DR   PDB; 3MID; X-ray; 3.06 A; A=43-356.
DR   PDB; 3MIE; X-ray; 3.26 A; A=43-356.
DR   PDB; 3MIF; X-ray; 2.00 A; A=43-356.
DR   PDB; 3MIG; X-ray; 2.70 A; A=43-356.
DR   PDB; 3MIH; X-ray; 2.74 A; A=43-356.
DR   PDB; 3MLJ; X-ray; 2.15 A; A=43-356.
DR   PDB; 3MLK; X-ray; 3.10 A; A=43-356.
DR   PDB; 3MLL; X-ray; 3.25 A; A=43-356.
DR   PDB; 3PHM; X-ray; 2.10 A; A=45-354.
DR   PDB; 4E4Z; X-ray; 1.98 A; A=45-356.
DR   PDB; 5WJA; X-ray; 2.30 A; A/D=45-356.
DR   PDB; 5WKW; X-ray; 1.79 A; A=45-356.
DR   PDB; 5WM0; X-ray; 2.40 A; A=1-976.
DR   PDB; 6ALA; X-ray; 2.59 A; A/C=45-356.
DR   PDB; 6ALV; X-ray; 3.50 A; A=45-356.
DR   PDB; 6AMP; X-ray; 2.48 A; A=45-356.
DR   PDB; 6AN3; X-ray; 2.05 A; A=45-356.
DR   PDB; 6AO6; X-ray; 2.98 A; A=45-356.
DR   PDB; 6AY0; X-ray; 2.60 A; A=45-356.
DR   PDB; 6NCK; X-ray; 2.70 A; A=45-356.
DR   PDB; 8DSJ; X-ray; 2.80 A; A/K=45-354.
DR   PDB; 8DSL; X-ray; 2.05 A; A/B=45-354.
DR   PDB; 8DSN; X-ray; 2.80 A; A/K=45-354.
DR   PDBsum; 1OPM; -.
DR   PDBsum; 1PHM; -.
DR   PDBsum; 1SDW; -.
DR   PDBsum; 1YI9; -.
DR   PDBsum; 1YIP; -.
DR   PDBsum; 1YJK; -.
DR   PDBsum; 1YJL; -.
DR   PDBsum; 3FVZ; -.
DR   PDBsum; 3FW0; -.
DR   PDBsum; 3MIB; -.
DR   PDBsum; 3MIC; -.
DR   PDBsum; 3MID; -.
DR   PDBsum; 3MIE; -.
DR   PDBsum; 3MIF; -.
DR   PDBsum; 3MIG; -.
DR   PDBsum; 3MIH; -.
DR   PDBsum; 3MLJ; -.
DR   PDBsum; 3MLK; -.
DR   PDBsum; 3MLL; -.
DR   PDBsum; 3PHM; -.
DR   PDBsum; 4E4Z; -.
DR   PDBsum; 5WJA; -.
DR   PDBsum; 5WKW; -.
DR   PDBsum; 5WM0; -.
DR   PDBsum; 6ALA; -.
DR   PDBsum; 6ALV; -.
DR   PDBsum; 6AMP; -.
DR   PDBsum; 6AN3; -.
DR   PDBsum; 6AO6; -.
DR   PDBsum; 6AY0; -.
DR   PDBsum; 6NCK; -.
DR   PDBsum; 8DSJ; -.
DR   PDBsum; 8DSL; -.
DR   PDBsum; 8DSN; -.
DR   AlphaFoldDB; P14925; -.
DR   SMR; P14925; -.
DR   BioGRID; 247540; 3.
DR   IntAct; P14925; 3.
DR   STRING; 10116.ENSRNOP00000046774; -.
DR   BindingDB; P14925; -.
DR   ChEMBL; CHEMBL4963; -.
DR   GlyCosmos; P14925; 1 site, No reported glycans.
DR   GlyGen; P14925; 1 site.
DR   iPTMnet; P14925; -.
DR   PhosphoSitePlus; P14925; -.
DR   jPOST; P14925; -.
DR   PaxDb; 10116-ENSRNOP00000046774; -.
DR   Ensembl; ENSRNOT00000041418.4; ENSRNOP00000050784.3; ENSRNOG00000033280.7. [P14925-6]
DR   Ensembl; ENSRNOT00000056457.6; ENSRNOP00000053295.2; ENSRNOG00000033280.7. [P14925-5]
DR   Ensembl; ENSRNOT00000117663.1; ENSRNOP00000089015.1; ENSRNOG00000033280.7. [P14925-4]
DR   Ensembl; ENSRNOT00000118414.1; ENSRNOP00000087123.1; ENSRNOG00000033280.7. [P14925-3]
DR   GeneID; 25508; -.
DR   KEGG; rno:25508; -.
DR   AGR; RGD:3252; -.
DR   CTD; 5066; -.
DR   RGD; 3252; Pam.
DR   VEuPathDB; HostDB:ENSRNOG00000033280; -.
DR   eggNOG; KOG3567; Eukaryota.
DR   GeneTree; ENSGT00940000156369; -.
DR   HOGENOM; CLU_891273_0_0_1; -.
DR   InParanoid; P14925; -.
DR   OrthoDB; 2908431at2759; -.
DR   PhylomeDB; P14925; -.
DR   BRENDA; 1.14.17.3; 5301.
DR   BRENDA; 4.3.2.5; 5301.
DR   SABIO-RK; P14925; -.
DR   EvolutionaryTrace; P14925; -.
DR   PRO; PR:P14925; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000033280; Expressed in heart and 19 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0000793; C:condensed chromosome; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:RGD.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0005507; F:copper ion binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0004598; F:peptidylamidoglycolate lyase activity; IDA:UniProtKB.
DR   GO; GO:0004504; F:peptidylglycine monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IDA:RGD.
DR   GO; GO:0062112; P:fatty acid primary amide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0007507; P:heart development; IEP:RGD.
DR   GO; GO:0007595; P:lactation; IEP:RGD.
DR   GO; GO:0060173; P:limb development; IEP:RGD.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:RGD.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEP:RGD.
DR   GO; GO:0007076; P:mitotic chromosome condensation; ISO:RGD.
DR   GO; GO:0022602; P:ovulation cycle process; IEP:RGD.
DR   GO; GO:0001519; P:peptide amidation; IDA:UniProtKB.
DR   GO; GO:0006518; P:peptide metabolic process; IDA:RGD.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IMP:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0046688; P:response to copper ion; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0009268; P:response to pH; IDA:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0010043; P:response to zinc ion; ISO:RGD.
DR   GO; GO:0009404; P:toxin metabolic process; IDA:RGD.
DR   CDD; cd14958; NHL_PAL_like; 1.
DR   Gene3D; 2.60.120.230; -; 1.
DR   Gene3D; 2.60.120.310; Copper type II, ascorbate-dependent monooxygenase, N-terminal domain; 1.
DR   Gene3D; 2.120.10.30; TolB, C-terminal domain; 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR014784; Cu2_ascorb_mOase-like_C.
DR   InterPro; IPR020611; Cu2_ascorb_mOase_CS-1.
DR   InterPro; IPR014783; Cu2_ascorb_mOase_CS-2.
DR   InterPro; IPR000323; Cu2_ascorb_mOase_N.
DR   InterPro; IPR036939; Cu2_ascorb_mOase_N_sf.
DR   InterPro; IPR024548; Cu2_monoox_C.
DR   InterPro; IPR001258; NHL_repeat.
DR   InterPro; IPR000720; PHM/PAL.
DR   InterPro; IPR008977; PHM/PNGase_F_dom_sf.
DR   PANTHER; PTHR10680; PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE; 1.
DR   PANTHER; PTHR10680:SF14; PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE; 1.
DR   Pfam; PF03712; Cu2_monoox_C; 1.
DR   Pfam; PF01082; Cu2_monooxygen; 1.
DR   Pfam; PF01436; NHL; 3.
DR   PRINTS; PR00790; PAMONOXGNASE.
DR   SUPFAM; SSF63829; Calcium-dependent phosphotriesterase; 1.
DR   SUPFAM; SSF49742; PHM/PNGase F; 2.
DR   PROSITE; PS00084; CU2_MONOOXYGENASE_1; 1.
DR   PROSITE; PS00085; CU2_MONOOXYGENASE_2; 1.
DR   PROSITE; PS51125; NHL; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium;
KW   Cleavage on pair of basic residues; Copper; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Lipid metabolism;
KW   Lyase; Membrane; Metal-binding; Monooxygenase; Multifunctional enzyme;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Repeat; Signal;
KW   Sulfation; Transmembrane; Transmembrane helix; Vitamin C; Zinc.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000269|PubMed:2211657"
FT   PROPEP          26..35
FT                   /id="PRO_0000006365"
FT   CHAIN           36..976
FT                   /note="Peptidylglycine alpha-amidating monooxygenase"
FT                   /id="PRO_0000006366"
FT   TOPO_DOM        36..866
FT                   /note="Intragranular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        867..890
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        891..976
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          501..544
FT                   /note="NHL 1"
FT   REPEAT          570..611
FT                   /note="NHL 2"
FT   REPEAT          620..665
FT                   /note="NHL 3"
FT   REPEAT          673..717
FT                   /note="NHL 4"
FT   REPEAT          769..812
FT                   /note="NHL 5"
FT   REGION          1..497
FT                   /note="Peptidylglycine alpha-hydroxylating monooxygenase"
FT   REGION          498..820
FT                   /note="Peptidyl-alpha-hydroxyglycine alpha-amidating lyase"
FT                   /evidence="ECO:0000269|PubMed:19604476"
FT   REGION          928..945
FT                   /note="Interaction with RASSF9"
FT                   /evidence="ECO:0000269|PubMed:9837933"
FT   REGION          940..976
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         107
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:10504734,
FT                   ECO:0007744|PDB:1OPM, ECO:0007744|PDB:3PHM"
FT   BINDING         108
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:10504734,
FT                   ECO:0007744|PDB:1OPM, ECO:0007744|PDB:3PHM"
FT   BINDING         172
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:10504734,
FT                   ECO:0007744|PDB:1OPM, ECO:0007744|PDB:3PHM"
FT   BINDING         242
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:10504734,
FT                   ECO:0007744|PDB:1OPM, ECO:0007744|PDB:3PHM"
FT   BINDING         244
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:10504734,
FT                   ECO:0007744|PDB:1OPM, ECO:0007744|PDB:3PHM"
FT   BINDING         314
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:10504734,
FT                   ECO:0007744|PDB:1OPM, ECO:0007744|PDB:3PHM"
FT   BINDING         520
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000269|PubMed:19604476,
FT                   ECO:0007744|PDB:3FVZ, ECO:0007744|PDB:3FW0"
FT   BINDING         533
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /ligand_part="C-terminal Xaa-(2S)-2-hydroxyglycine residue"
FT                   /ligand_part_id="ChEBI:CHEBI:142768"
FT                   /evidence="ECO:0000305|PubMed:19604476,
FT                   ECO:0007744|PDB:3FW0"
FT   BINDING         585
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:19604476,
FT                   ECO:0007744|PDB:3FVZ"
FT   BINDING         587
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000269|PubMed:19604476,
FT                   ECO:0007744|PDB:3FVZ, ECO:0007744|PDB:3FW0"
FT   BINDING         654
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /ligand_part="C-terminal Xaa-(2S)-2-hydroxyglycine residue"
FT                   /ligand_part_id="ChEBI:CHEBI:142768"
FT                   /evidence="ECO:0000305|PubMed:19604476,
FT                   ECO:0007744|PDB:3FW0"
FT   BINDING         690
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:19604476,
FT                   ECO:0007744|PDB:3FVZ"
FT   BINDING         706
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /ligand_part="C-terminal Xaa-(2S)-2-hydroxyglycine residue"
FT                   /ligand_part_id="ChEBI:CHEBI:142768"
FT                   /evidence="ECO:0000305|PubMed:19604476,
FT                   ECO:0007744|PDB:3FW0"
FT   BINDING         786
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:19604476,
FT                   ECO:0007744|PDB:3FVZ"
FT   BINDING         787
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000269|PubMed:19604476,
FT                   ECO:0007744|PDB:3FVZ, ECO:0007744|PDB:3FW0"
FT   MOD_RES         921
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19021"
FT   MOD_RES         932
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19021"
FT   MOD_RES         945
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         946
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P19021"
FT   MOD_RES         949
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         959
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         961
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        765
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:2211657"
FT   DISULFID        47..186
FT                   /evidence="ECO:0000269|PubMed:12369828"
FT   DISULFID        81..126
FT                   /evidence="ECO:0000269|PubMed:12369828"
FT   DISULFID        114..131
FT                   /evidence="ECO:0000269|PubMed:12369828"
FT   DISULFID        227..334
FT                   /evidence="ECO:0000269|PubMed:12369828"
FT   DISULFID        293..315
FT                   /evidence="ECO:0000269|PubMed:12369828"
FT   DISULFID        634..655
FT                   /evidence="ECO:0000269|PubMed:12369828"
FT   DISULFID        702..713
FT                   /evidence="ECO:0000269|PubMed:12369828"
FT   VAR_SEQ         308..312
FT                   /note="GTSSD -> FKDTF (in isoform PAM-5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001230"
FT   VAR_SEQ         313..976
FT                   /note="Missing (in isoform PAM-5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001231"
FT   VAR_SEQ         393..497
FT                   /note="Missing (in isoform PAM-2, isoform PAM-3, isoform
FT                   PAM-3A and isoform PAM-3B)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001232"
FT   VAR_SEQ         498..517
FT                   /note="DFHVEEELDWPGVYLLPGQV -> GASRISFTQKKKCVKHCNPH (in
FT                   isoform PAM-4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001236"
FT   VAR_SEQ         518..917
FT                   /note="Missing (in isoform PAM-4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001237"
FT   VAR_SEQ         832..917
FT                   /note="Missing (in isoform PAM-3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001234"
FT   VAR_SEQ         832..899
FT                   /note="Missing (in isoform PAM-3A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001233"
FT   VAR_SEQ         900..917
FT                   /note="Missing (in isoform PAM-3B)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001235"
FT   MUTAGEN         533
FT                   /note="R->A: Abolishes peptidyl-alpha-hydroxyglycine alpha-
FT                   amidating lyase activity."
FT                   /evidence="ECO:0000269|PubMed:19604476"
FT   MUTAGEN         533
FT                   /note="R->Q: Abolishes peptidyl-alpha-hydroxyglycine alpha-
FT                   amidating lyase activity."
FT                   /evidence="ECO:0000269|PubMed:19604476"
FT   MUTAGEN         706
FT                   /note="R->A: Abolishes peptidyl-alpha-hydroxyglycine alpha-
FT                   amidating lyase activity."
FT                   /evidence="ECO:0000269|PubMed:19604476"
FT   MUTAGEN         706
FT                   /note="R->Q: Reduces peptidyl-alpha-hydroxyglycine alpha-
FT                   amidating lyase activity."
FT                   /evidence="ECO:0000269|PubMed:19604476"
FT   MUTAGEN         784
FT                   /note="M->A: Abolishes peptidyl-alpha-hydroxyglycine alpha-
FT                   amidating lyase activity."
FT                   /evidence="ECO:0000269|PubMed:19604476"
FT   MUTAGEN         784
FT                   /note="M->Q: Abolishes peptidyl-alpha-hydroxyglycine alpha-
FT                   amidating lyase activity."
FT                   /evidence="ECO:0000269|PubMed:19604476"
FT   MUTAGEN         787
FT                   /note="D->A: Reduces peptidyl-alpha-hydroxyglycine alpha-
FT                   amidating lyase activity."
FT                   /evidence="ECO:0000269|PubMed:19604476"
FT   CONFLICT        959
FT                   /note="T -> S (in Ref. 4; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   HELIX           49..51
FT                   /evidence="ECO:0007829|PDB:1PHM"
FT   STRAND          53..56
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          58..67
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          69..71
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          75..85
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:6ALV"
FT   STRAND          92..100
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   TURN            103..105
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          106..118
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          121..125
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   HELIX           126..128
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          130..133
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          136..142
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          154..159
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   TURN            160..162
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          166..173
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   HELIX           178..181
FT                   /evidence="ECO:0007829|PDB:1SDW"
FT   STRAND          188..196
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          199..209
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          211..214
FT                   /evidence="ECO:0007829|PDB:5WKW"
FT   STRAND          219..228
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          234..245
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          247..256
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          259..266
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          268..270
FT                   /evidence="ECO:0007829|PDB:8DSJ"
FT   STRAND          275..283
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          288..296
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:8DSN"
FT   STRAND          304..307
FT                   /evidence="ECO:0007829|PDB:5WKW"
FT   STRAND          315..324
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   HELIX           325..327
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          330..334
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          336..338
FT                   /evidence="ECO:0007829|PDB:5WKW"
FT   HELIX           340..345
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   HELIX           348..351
FT                   /evidence="ECO:0007829|PDB:1YI9"
FT   STRAND          498..503
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   HELIX           508..511
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          517..522
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          528..532
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   HELIX           552..554
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          562..565
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            567..569
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          572..576
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            578..580
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          582..589
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          595..599
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            600..603
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          604..608
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          617..622
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          634..641
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            643..645
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          648..652
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          658..662
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          668..672
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          678..680
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          685..687
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          689..695
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            696..699
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          700..705
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            706..709
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          710..715
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            716..718
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          721..725
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            728..732
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          734..740
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          743..748
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          761..765
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   TURN            766..768
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          771..775
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          778..780
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          783..790
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          794..803
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   STRAND          806..813
FT                   /evidence="ECO:0007829|PDB:3FVZ"
FT   MOD_RES         P14925-3:774
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P14925-4:792
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   976 AA;  108675 MW;  7233021BEBEFD9B9 CRC64;
     MAGRARSGLL LLLLGLLALQ SSCLAFRSPL SVFKRFKETT RSFSNECLGT IGPVTPLDAS
     DFALDIRMPG VTPKESDTYF CMSMRLPVDE EAFVIDFKPR ASMDTVHHML LFGCNMPSST
     GSYWFCDEGT CTDKANILYA WARNAPPTRL PKGVGFRVGG ETGSKYFVLQ VHYGDISAFR
     DNHKDCSGVS VHLTRVPQPL IAGMYLMMSV DTVIPPGEKV VNADISCQYK MYPMHVFAYR
     VHTHHLGKVV SGYRVRNGQW TLIGRQNPQL PQAFYPVEHP VDVTFGDILA ARCVFTGEGR
     TEATHIGGTS SDEMCNLYIM YYMEAKYALS FMTCTKNVAP DMFRTIPAEA NIPIPVKPDM
     VMMHGHHKEA ENKEKSALMQ QPKQGEEEVL EQGDFYSLLS KLLGEREDVH VHKYNPTEKT
     ESGSDLVAEI ANVVQKKDLG RSDAREGAEH EEWGNAILVR DRIHRFHQLE STLRPAESRA
     FSFQQPGEGP WEPEPSGDFH VEEELDWPGV YLLPGQVSGV ALDSKNNLVI FHRGDHVWDG
     NSFDSKFVYQ QRGLGPIEED TILVIDPNNA EILQSSGKNL FYLPHGLSID TDGNYWVTDV
     ALHQVFKLDP HSKEGPLLIL GRSMQPGSDQ NHFCQPTDVA VEPSTGAVFV SDGYCNSRIV
     QFSPSGKFVT QWGEESSGSS PRPGQFSVPH SLALVPHLDQ LCVADRENGR IQCFKTDTKE
     FVREIKHASF GRNVFAISYI PGFLFAVNGK PYFGDQEPVQ GFVMNFSSGE IIDVFKPVRK
     HFDMPHDIVA SEDGTVYIGD AHTNTVWKFT LTEKMEHRSV KKAGIEVQEI KEAEAVVEPK
     VENKPTSSEL QKMQEKQKLS TEPGSGVSVV LITTLLVIPV LVLLAIVMFI RWKKSRAFGD
     HDRKLESSSG RVLGRFRGKG SGGLNLGNFF ASRKGYSRKG FDRVSTEGSD QEKDEDDGTE
     SEEEYSAPLP KPAPSS
//
